Teladoc Health今日盘前股价大跌15.01%,主要是因为公司公布的2024年第四季度财报令市场失望。
财报显示,尽管Teladoc Health第四季度销售额达到6.405亿美元,高于分析师预期,但同比下滑了3.03%,增长放缓引发市场担忧。更糟糕的是,Teladoc Health每股亏损高达0.28美元,不仅远超预期的0.23美元亏损,而且亏损规模较去年同期扩大64.71%。
销售额增长乏力加上亏损大幅扩大,这两个核心财务指标的恶化导致市场对Teladoc Health未来业务前景失去信心,因此在盘前大幅抛售该股,造成股价大跌15.01%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.